Retesting. If the Works, or a Section, fail to pass the Tests on Completion, sub-clause 7.5 [Rejection] shall apply, and the Engineer or the Contractor may require the failed Tests, and Tests on Completion on any related work, to be repeated under the same terms and conditions.
Retesting. If as a result of any test, whether originally specified or not, any material or Work is found to be unacceptable, it shall be rejected, and all further sampling and testing required by District or District Representative shall be at Contractor’s expense.
Retesting. All employees will be re-tested by the City annually. Following the re-tests, the City will evaluate the test and retest results. A meeting shall be scheduled with the Union to discuss the results.
Retesting. The Employee will have the opportunity to discuss the positive test result with the Employer and may, at the Employee’s own expense, have another test run on a second sample. The Township will contest all workers’ compensation claims under circumstances in which an Employee tests positive for illegal drugs or alcohol or refuses to be tested. Employees should understand that the failure of a drug or alcohol test or the refusal to submit to such a test may lead to the denial of workers’ compensation benefits. An Employee’s violation under this policy will not be reported to law enforcement officials or other regulatory bodies, except when required by law.
Retesting. If the Works, or a Section, fail to pass the Tests after Completion:
Retesting. When the MRO has confirmed a positive test result, the employee or his/her representative may request that a GC/MS test of Specimen B be conducted at an independent lab of the employee’s choice described in Appendix A. The District shall pay for retesting. If the test results are positive, an independent Medical Review Officer selected and compensated by the employee or his/her representative will review the findings and interview the employee (at the employee’s option). The independent MRO will prepare an advisory report to be given to the Drug Abuse Program Director with a copy to the employee. If the test results from the independent lab are negative, no further action will be taken. If the test results from the independent lab are positive, no further independent testing will be allowed.
Retesting. When the Laboratory has confirmed a positive test result, the Employee or his/her representative may request that a GC/MS test of Specimen B be conducted at an independent lab (refer to Appendix A for a list of laboratories). If the test results are positive, an independent Medical Review Officer selected by the employee or his/her representative will review the findings and interview the employee (at his/her option). The MRO will prepare an advisory report to be given to the Drug Abuse Program Director with a copy to the employee. Internal Affairs and the employee will be notified by the Program Director. A pre-disciplinary hearing (Xxxxxx) may take place as a result of the investigation. If the results of the first independent lab are negative, The Drug Abuse Program Director may request that GC/MS test of Specimens A and B be performed at a second independent lab (refer to Appendix A for the list of the laboratories). If the test results from the second independent lab are negative, or if the Program Director elects not to have a second independent chemical test, no further action will be taken. If the test results from the second independent lab are positive, an independent Medical Review Officer will review the findings and interview the employee (at his/her option). The MRO will prepare an advisory report to be given to the Drug Abuse Program Director with a copy to the employee. Internal Affairs and the employee will be notified by the Program Director. A pre-disciplinary hearing (Xxxxxx) may take place as a result of the investigation. The results of the third analysis (samples A and B) shall be deemed conclusive. The Department shall pay for all such retesting. However, results of drug tests not obtained within the specifications of the Drug Testing Program and not processed by a laboratory mutually agreed to by the union and management shall not be considered.
Retesting. All retesting performed that is not directly due to Cardinal Health’s gross negligence, willful misconduct or breach of this Agreement, the Quality Agreement or a SOW will be billed to the Xencor. All required investigational studies or additional Xencor requests not outlined in the SOW will be invoiced for the cost of performance at the current standard hourly rate; plus any associated fees.
Retesting. All retesting performed that is not due to a Catalent error will be billed to Client. All required investigational studies or additional Client requests not outlined in the Development Program will be invoiced for the cost of performance at the current standard pricing.
Retesting. An employee shall be entitled to retesting in accordance with appropriate regulations. SECTION 11.03:
